Back to Search
Start Over
DAAs and HBV/HCV coinfection: Glimmer of light and a few shades of grey.
- Source :
-
Journal of hepatology [J Hepatol] 2020 Aug; Vol. 73 (2), pp. 461. Date of Electronic Publication: 2020 Apr 20. - Publication Year :
- 2020
-
Abstract
- Competing Interests: Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
- Subjects :
- Antiviral Agents therapeutic use
Hepatitis B virus
Humans
Coinfection drug therapy
Hepatitis B complications
Hepatitis B drug therapy
Hepatitis B, Chronic complications
Hepatitis B, Chronic drug therapy
Hepatitis C complications
Hepatitis C drug therapy
Hepatitis C, Chronic complications
Hepatitis C, Chronic drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1600-0641
- Volume :
- 73
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of hepatology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 32327362
- Full Text :
- https://doi.org/10.1016/j.jhep.2020.03.010